Adebrelimab combined with irinotecan liposomal (II), oxaliplatin, and 5-FU/LV
PC-IIT-003
Phase 2 small_molecule active
Quick answer
Adebrelimab combined with irinotecan liposomal (II), oxaliplatin, and 5-FU/LV for Pancreatic Cancer is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Pancreatic Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active